Nelson Sonja 4
4 · Ambrx Biopharma, Inc. · Filed Dec 11, 2023
Insider Transaction Report
Form 4
Nelson Sonja
Chief Financial Officer
Transactions
- Award
Common Stock
2023-12-11+50,000→ 545,776 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") payable in common stock of the Issuer granted to the Reporting Person on December 11, 2023 (the "Grant Date"). The RSUs were granted in connection with the completion of the year-end review process and will be issued pursuant to the Company's Amended and Restated 2021 Equity Incentive Plan.
- [F2]The RSUs will vest over thirty-six (36) months as follows: (i) one-sixth (1/6) of the RSUs will vest on the six (6)-month anniversary of the Grant Date, and (ii) one-twelfth (1/12) of the RSUs will vest on a quarterly basis thereafter.